Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation
Top Cited Papers
- 24 April 2020
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 368 (6489), 387-+
- https://doi.org/10.1126/science.aaz8455
Abstract
The two tandem bromodomains of the BET (bromodomain and extraterminal domain) proteins enable chromatin binding to facilitate transcription. Drugs that inhibit both bromodomains equally have shown efficacy in certain malignant and inflammatory conditions. To explore the individual functional contributions of the first (BD1) and second (BD2) bromodomains in biology and therapy, we developed selective BD1 and BD2 inhibitors. We found that steady- state gene expression primarily requires BD1, whereas the rapid increase of gene expression induced by inflammatory stimuli requires both BD1 and BD2 of all BET proteins. BD1 inhibitors phenocopied the effects of pan-BET inhibitors in cancer models, whereas BD2 inhibitors were predominantly effective in models of inflammatory and autoimmune disease. These insights into the differential requirement of BD1 and BD2 for the maintenance and induction of gene expression may guide future BET-targeted therapies.Funding Information
- Howard Hughes Medical Institute
- Victorian Cancer Agency
- Victorian Cancer Agency
- Cancer Council Victoria
- NHMRC (1106444)
This publication has 44 references indexed in Scilit:
- Small-Molecule Inhibition of BRDT for Male ContraceptionCell, 2012
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain FamilyCell, 2012
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaNature, 2011
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-MycCell, 2011
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemiaNature, 2011
- Structural Basis and Specificity of Acetylated Transcription Factor GATA1 Recognition by BET Family Bromodomain Protein Brd3Molecular and Cellular Biology, 2011
- Data processing and analysis with theautoPROCtoolboxActa Crystallographica Section D-Structural Biology, 2011
- Overview of theCCP4 suite and current developmentsActa Crystallographica Section D-Structural Biology, 2011
- Selective inhibition of BET bromodomainsNature, 2010
- Brd2 disruption in mice causes severe obesity without Type 2 diabetesBiochemical Journal, 2009